Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hartung

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|January 31, 2023
Tolvaptan for Autosomal Dominant Polycystic Kidney Disease in Children: Why, Who, and When?Erum A Hartung
Pediatric Nephrology (Berlin, Germany)|May 19, 2015
Biomarkers and surrogate endpoints in kidney diseaseErum A Hartung
Pediatrics in Review|December 10, 1999
Index of suspicion. Case 1. Diagnosis: acute vertebral osteomyelitisB J Bradford, A Hartung
Analytical Chemistry|February 14, 2012
Exact treatment of diffusion in gas chromatographyH A Hartung, R W Dwyer
Pediatric Nephrology (Berlin, Germany)|June 25, 2013
Growth in children on renal replacement therapy: a shrinking problem?Erum A Hartung, Susan L Furth
Pediatric Nephrology (Berlin, Germany)|June 23, 2021
Correction to: "Predictors of progression in autosomal dominant and autosomal recessive polycystic kidney disease"Eric G Benz, Erum A Hartung
Der Anaesthesist|April 1, 1995
[Three isoflurane preparations from various manufacturers. A comparison of isoflurane concentrations in fresh gas after vaporization with a Drager vaporizer type 19.3]W Wilhelm, A Hartung, R Larsen
Pediatric Nephrology (Berlin, Germany)|January 21, 2021
Predictors of progression in autosomal dominant and autosomal recessive polycystic kidney diseaseEric G Benz, Erum A Hartung
Pediatric Nephrology (Berlin, Germany)|April 27, 2024
Approach to simple kidney cysts in childrenKatherine M Dell, Erum A Hartung
Pediatrics|August 13, 2014
Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effectsErum A Hartung, Lisa M Guay-Woodford
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Clinical Journal of the American Society of Nephrology : CJASN|January 31, 2023
Tolvaptan for Autosomal Dominant Polycystic Kidney Disease in Children: Why, Who, and When?Erum A Hartung
Pediatric Nephrology (Berlin, Germany)|May 19, 2015
Biomarkers and surrogate endpoints in kidney diseaseErum A Hartung
Pediatrics in Review|December 10, 1999
Index of suspicion. Case 1. Diagnosis: acute vertebral osteomyelitisB J Bradford, A Hartung
Analytical Chemistry|February 14, 2012
Exact treatment of diffusion in gas chromatographyH A Hartung, R W Dwyer
Pediatric Nephrology (Berlin, Germany)|June 25, 2013
Growth in children on renal replacement therapy: a shrinking problem?Erum A Hartung, Susan L Furth
Pediatric Nephrology (Berlin, Germany)|June 23, 2021
Correction to: "Predictors of progression in autosomal dominant and autosomal recessive polycystic kidney disease"Eric G Benz, Erum A Hartung
Der Anaesthesist|April 1, 1995
[Three isoflurane preparations from various manufacturers. A comparison of isoflurane concentrations in fresh gas after vaporization with a Drager vaporizer type 19.3]W Wilhelm, A Hartung, R Larsen
Pediatric Nephrology (Berlin, Germany)|January 21, 2021
Predictors of progression in autosomal dominant and autosomal recessive polycystic kidney diseaseEric G Benz, Erum A Hartung
Pediatric Nephrology (Berlin, Germany)|April 27, 2024
Approach to simple kidney cysts in childrenKatherine M Dell, Erum A Hartung
Pediatrics|August 13, 2014
Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effectsErum A Hartung, Lisa M Guay-Woodford
Pageof 9